Research Article
Aspirin Use in Rheumatoid Arthritis Patients with Increased Risk of Cardiovascular Disease
Table 1
Baseline characteristics of RA patients with a Framingham score ≥10%.
| | Baseline patient characteristics | All patients | Aspirin use | No aspirin use |
| | Age (mean) | 62.2 | 65.5 | 61.0 | | Male gender (%) | 24 (77) | 6 (75) | 18 (78) | | Smoking (%) | 12 (39) | 2 (25) | 10 (43) | | RF+ (%) | 24 (77) | 7 (86) | 17 (74) | | RF− (%) | 10 (30) | 1 (13) | 6 (26) | | Anti-CCP+ (%) | 13 (42) | 3 (38) | 10 (43) | | Anti-CCP− (%) | 7 (23) | 1 (13) | 6 (26) | | Anti-CCP unavailable (%) | 11 (35) | 4 (50) | 7 (30) | | EULAR risk score ≥ 15 (%) | 19 (61) | 5 (63) | 14 (61) | | Prednisone use (%) | 12 (39) | 1 (13) | 11 (48) | | NSAID use (%) | 11 (35) | 2 (25) | 9 (39) | | Both prednisone and NSAID use | 6 (19) | 1 (13) | 5 (22) |
|
|
RF: rheumatoid factor; anti-CCP: anti-cyclic citrullinated peptide antibodies; EULAR: European League Against Rheumatism; NSAID: nonsteroidal anti-inflammatory drugs.
|
